COMPOSITIONS AND METHODS FOR LOGIC-GATED PROFILING OF BIOLOGIC ACTIVITY

Formation of Array of Membranes and Apparatus Therefor

COMBINATORIAL HIGH-THROUGHPUT SCREENING OF COMPLEX POLYMERIC ENZYME IMMOBILIZATION SUPPORTS

THROMBIN AND FIBRINOGEN AS TARGETS FOR ATOPIC DERMATITIS DIAGNOSIS AND TREATMENT

FORMATION OF ARRAY OF MEMBRANES AND APPARATUS THEREFOR

HEMOSTATIC ENZYME AND CARBOXYMETHYL CHITOSAN-CONTAINING COMPOSITION FOR BLOOD COAGULATION TEST, AND USE THEREOF

METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS

COVALENT APTAMERS

Formation of Array of Membranes and Apparatus Therefor

Formation of Array of Membranes and Apparatus Therefor

METHOD FOR DETERMINING FIBRINOGEN

A METHOD TO IDENTIFY LVAD PATIENTS WITH ELEVATED LEVELS OF BLOOD ACTIVATION USING COUPON TESTS

DEVICE FOR DETECTING BLOOD COAGULATION CHARACTERISTICS AND APPLICATION OF DEVICE

AUTOMATED PLATFORM TO TREAT TRAUMA-INDUCED COAGULOPATHY WITH PERSONALIZED COAGULATION FACTOR CONCENTRATIONS

BLOOD COAGULATION TEST REAGENT, AND BLOOD COAGULATION TEST METHOD

BIOLOGICAL AND/OR BIOCHEMICAL AND/OR CHEMICAL SENSOR

METHOD FOR FIBRINOGEN MEASUREMENT

METHODS OF DIAGNOSING MALIGNANT DISEASES

METHODS AND KITS FOR IDENTIFYING THROMBUS ORIGIN AND OPTIMIZING POST-ISCHEMIC EVENT TREATMENT

METHODS AND DEVICES FOR DETECTION OF COAGULATION IMPAIRMENT

METHOD FOR DETERMINING THE INTERACTION BETWEEN A LIGAND AND A RECEPTOR

METHOD AND DEVICE FOR MEASURING THE FIBRINOGEN CONCENTRATION IN BLOOD SAMPLES

Hemostatic Enzyme and Carboxymethyl Chitosan-Containing Composition for Blood Coagulation Test, and Use Thereof

STABILIZED THROMBIN

FORMATION OF ARRAY OF MEMBRANES AND APPARATUS THEREFOR

Atypical hemolytic uremic syndrome (AHUS) biomarker proteins

Method of selecting stem cells having ability to produce extracellular vesicles with high efficiency using activation of protease-activated receptor-mediated signaling pathways

Aluminum metasurfaces for highly sensitive and enhanced detection of analytes for smartphone diagnostics and methods for making and using the same

Method for determining the interaction between a ligand and a receptor

METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS

Disease detection method

Formation of array of membranes and apparatus therefor

Assays to monitor bleeding disorders

COMPOSITIONS AND METHODS FOR LOGIC-GATED PROFILING OF BIOLOGIC ACTIVITY

Device for monitoring the spatial and temporal dynamics of thrombin

Reagent and method for assaying thrombin-antithrombin complex

Affinity-based detection of ligand-encoded synthetic biomarkers

Biomarkers for cognitive impairment and methods for detecting cognitive impairment using such biomarkers

METHOD FOR EVALUATING SEVERITY OF DENGUE VIRUS INFECTION IN INDIVIDUAL, DETECTION DEVICE AND DETECTION

Biomarker for mental disorders including cognitive disorders, and method using said biomarker to detect mental disorders including cognitive disorders

Methods of diagnosing malignant diseases

Identification of anticoagulants in a sample

ASSAY KIT AND METHOD FOR DETECTING MODULATORS OF GPIB-THROMBIN INTERACTION

Stabilized thrombin

CARTRIDGE DEVICE WITH SEGMENTED FLUIDICS FOR ASSAYING COAGULATION IN FLUID SAMPLES

Cartridge device with fluidic junctions for coagulation assays in fluid samples

NOVEL ARTIFICIAL PHOSPHOLIPID-PROTEIN BIOCONJUGATES FOR BIOMOLECULAR RECOGNITION

Apparatus and Method to Determine Stroke Subtype

Reagent and method for measuring thrombin-antithrombin complex

Ellagic acid formulations for use in coagulation assays

SYSTEMS AND METHODS FOR MULTIPLEXED HEMOSTASIS TEST PANELS

Sensors for assaying coagulation in fluid samples

Thrombin-thrombomodulin fusion proteins as protein C activators

REAGENT AND METHOD FOR ASSAYING THROMBIN-ANTITHROMBIN COMPLEX

METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS

NOVEL BIOMARKERS FOR COGNITIVE IMPAIRMENT AND METHODS FOR DETECTING COGNITIVE IMPAIRMENT USING SUCH BIOMARKERS

BIOMARKER FOR COGNITIVE DYSFUNCTION DISEASES, AND METHOD FOR DETECTION OF COGNITIVE DYSFUNCTION DISEASES USING THE BIOMARKER

Reagent for prothrombin time measurement, method for production thereof, and method for measurement of prothrombin time

Reagent for prothrombin time measurement, method for production thereof, and method for measurement of prothrombin time

BIOMARKER FOR COGNITIVE DYSFUNCTION DISEASES, AND METHOD FOR DETECTION OF COGNITIVE DYSFUNCTION DISEASES USING THE BIOMARKER

ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS

Binding detection using liquid crystal

NANOSENSOR FOR ASSESSING THROMBIN INHIBITORS

METHOD AND SYSTEM FOR ASSEMBLING A MICROFLUIDIC SENSOR

Pincers comprising antibody and aptamer conjugated via a linker which binds to the same target material and use thereof

Atypical hemolytic uremic syndrome (aHUS) biomarker proteins

Method for assaying a protease

IDENTIFICATION OF ANTICOAGULANTS IN A SAMPLE

Specific peptide binders to proteins identified via systematic discovery, maturation and extension process

Method for detecting proteins by means of aptamers

Method and system for determination of molecular interaction parameters

Sensor, detection method, detection system, and detection apparatus

Atypical hemolytic uremic syndrome (AHUS) biomarker proteins

Ellagic acid formulations for use in coagulation assays

Cartridge device with fluidic junctions for coagulation assays in fluid samples

Cartridge device with segmented fluidics for assaying coagulation in fluid samples

Sensors for assaying coagulation in fluid samples

Kit with stabilized thrombin

Measurement method for thrombin production

Formation of array of membranes and apparatus therefor

Method for detecting modulators of GPIb-thrombin interaction

Immunoassay for thrombin detection

LYOPHILISED DABIGATRAN

BINDING-INDUCED FORMATION OF DNA THREE-WAY JUNCTIONS FROM NON-DNA TARGETS

BIOMARKER FOR COGNITIVE DYSFUNCTION DISEASES, AND METHOD FOR DETECTION OF COGNITIVE DYSFUNCTION DISEASES USING THE BIOMARKER

Simultaneous measurement of thrombin generation and clot strength in plasma and whole blood

Method for simultaneously determining multiple coagulation proteases

Assays to monitor bleeding disorders

Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity

BIOMARKER FOR MENTAL DISORDERS INCLUDING COGNITIVE DISORDERS, AND METHOD USING SAID BIOMARKER TO DETECT MENTAL DISORDERS INCLUDING COGNITIVE DISORDERS

Affinity-based detection of ligand-encoded synthetic biomarkers

Method for determining the spatiotemporal distribution of activity of a proteolytic enzyme in a heterogeneous system (variations), a device for realizing same and a method for diagnosing the defects in the hemostatic system on the basis of a change in the spatiotemporal distribution of activity of a proteolytic enzyme in a heterogeneous system

Detection of protease and protease activity using a single nanocrescent SERS probe

Method for separating target molecules or particles from fibrinogen-containing samples including blood components

Method for simultaneously determining multiple coagulation proteases

Biomarker for psychiatric diseases including cognitive impairment and methods for detecting psychiatric diseases including cognitive impairment using the biomarkers

Immunoassay for thrombin detection

Lyophilised dabigatran

Nucleic acid ligand complexes

Method and system for determination of molecular interaction parameters

Method for purifying or detecting a target protein

Method for monitoring, diagnosing, and screening cancer through measuring the concentration of des-R prothrombin activation peptide fragment F2 (des-R F2) in a serum

Time-course measurement of enzymatic activity corrected for impacts of disturbances relating to the reaction of the enzyme with a substrate

TUNABLE AFFINITY LIGANDS FOR THE SEPARATION AND DETECTION OF TARGET SUBSTANCES

Blood coagulation assays

Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity

Detection of protease and protease activity using a single nanoscrescent SERS probe

Measuring thrombin activity in whole blood

High Affinity Nucleic Acid Ligands To Lectins

MASS SPECTROMETRY-BASED QUANTITATIVE ASSAY FOR DETERMINING ABUNDANCE OF MOLECULAR SPECIES IN A COMPOSITION

Labeling enzyme

Screening method for a growth inhibitor or promoter of a vascular smooth muscle cell

Method and system for determination of molecular interaction parameters

Method for determining the total clotting activity of a blood or plasma sample

Method of detecting platelet thrombosis or organ failure

Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor

System for differential determination of a proteolytic enzyme level in a bodily fluid

Methods and reagents for protease inhibition

Tenascin-C nucleic acid ligands

Systematic evolution of ligands by exponential enrichment: Chemi-SELEX

High affinity TGFbeta nucleic acid ligands and inhibitors

Novel bicyclic hydroxamates as inhibitors of histone deacetylase

Nucleic acid ligand complexes

Truncation SELEX method

High affinity RNA ligands of basic fibroblast growth factor

Methods and reagents for protease inhibition

Method and system for determination of molecular interaction parameters